(Q37947556)

25 August 2017

title

Collaborative ocular melanoma study randomized trial of I-125 brachytherapy (English)

1 reference

25 August 2017

1 reference

1 reference

1 reference

Barbara S Hawkins

1

1 reference

25 August 2017

publication date

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

661-673

1 reference

A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Time trends in personnel certification and turnover in the Collaborative Ocular Melanoma Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Comparison of clinical, echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the collaborative ocular melanoma study: COMS report no. 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Sociodemographic and clinical predictors of participation in two randomized trials: findings from the Collaborative Ocular Melanoma Study COMS report no. 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Cause-specific mortality coding. methods in the collaborative ocular melanoma study coms report no. 14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Feasibility of keying data from screen-displayed facsimile images in an ongoing trial: the collaborative ocular melanoma study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Mortality after deferral of treatment or no treatment for choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Comparison of survival among eligible patients not enrolled versus enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

Treatment of metastatic uveal melanoma: review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled COMS report no. 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings COMS report no. 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419684

21 January 2018

Identifiers

DOI

10.1177/1740774511419684

1 reference

25 August 2017

1 reference